Page 33 - தனிப்பட்ட பராமரிப்பு ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs 07-Apr-2021 Rare Neurological Disease Treatment Market to Surpass US$12,000 Mn, with Heightened Investments in Orphan Drugs, Says FMI According to a newly published Future Market Insights report, the global rare neurological disease treatment market will exhibit a splendid expansion throughout the forecast period (2017-2026). Revenues from the market are envisaged to exceed US$ 12,000 Mn by 2026-end. New Drug Formulations and Initiatives toward Improving Treatment & Care of Patients to Influence Market Growth Declining blockbuster drugs have led pharmaceutical companies to keenly investigate potential new areas of research & development. Drug manufacturers have been incentivized by the Orphan Drug Act to develop new drug formulations associated with treatment of various rare diseases such as rare neurological diseases, in a bid to introduce new treatment options to the market. Regulatory advantages such as breakthrough

United arab emiratesUnited statesUnited kingdomBayer aktiengesellschaftBiotechnology companiesJazz pharmaceuticalsSerono incMedtronic plcAccess to research methodologyBrains for brain foundationTeva pharmaceutical industriesEuropean brain councilFuture market insightsDrug formulationsImproving treatmentInfluence market